ENDO PHARMACEUTICALS ADDRESS TRIAL

NovemHoldouts In Alexion Insider Trading Case Get May Trial DateĪ Manhattan federal judge set a May 2024 trial date Monday for the last two defendants to deny their participation in an alleged five-man insider trading ring revolving around Alexion Pharmaceuticals Inc.'s $1.4 billion purchase of another biotech firm.Department of Commerce issued to an Indian glycine producer that offered officials contradictory evidence on whether it had ties with other glycine companies in India. Court of International Trade stood by the penalty tariffs the U.S. NovemIndian Glycine Co.'s Waffling Justifies Penalty Duties.Food and Drug Administration has withdrawn from the medical device regulatory working group Global Harmonization Working Party just two years after joining in 2021, saying the group lacked the effort to work with other international regulatory authorities. NovemFDA Quits Global Med Device Regulatory Group.Patent and Trademark Office director should throw out a sanctions order against it, given as punishment for when a patent owner withholds key evidence from the Patent Trial and Appeal Board. Longhorn Vaccines & Diagnostics LLC says the U.S. NovemLonghorn Vaccines Urges Vidal To Ax PTAB Sanctions Order.over a migraine drug - an action taken after the Patent Trial and Appeal Board found two patents related to the drug and its use invalid. Teva Pharmaceuticals International GmbH has moved in Massachusetts federal court to permanently drop an infringement case against Eli Lilly and Co. NovemTeva, Eli Lilly Call Off Infringement Suit Over Migraine Drug.in its patent dispute with P Tech LLC, finding as obvious two additional P Tech surgery patents that are being litigated in federal district court. The Patent Trial and Appeal Board has again sided with medical device company Arthrex Inc. NovemArthrex Gets PTAB To Strike Down More P Tech Patents.The Patent Trial and Appeal Board has denied a petition by biotechnology company Microbiotica seeking post-grant review of a cancer treatment patent held by the University of Texas System. NovemRegeneron False Claims Act Case Paused Amid AppealĪ Massachusetts federal judge has pressed pause on a False Claims Act case against Regeneron while the First Circuit decides whether his interpretation of the law's causation standard or that of his colleague in the same courthouse is correct.The federal government is formulating a plan to expand access to medication for opioid abuse following an analysis published Monday that shows low risk for misuse of the drug buprenorphine. NovemHHS' OIG Finds Low Risk Of Misuse For Opioid Treatment Drug.Supreme Court to overturn a decades-old legal doctrine stating that courts must defer to federal agencies' interpretation of ambiguous laws. Six groups, including the Ohio Chamber of Commerce and several former state supreme court judges, filed friend-of-the-court briefs on Monday urging the U.S.

NovemAmicus Groups Tell High Court To End Chevron Deference.and its executives misled the public about the company's growth prospects for the year amid inflation and an uptick in competition.

Levi & Korsinsky LLP and Pomerantz LLP want to represent a proposed class of investors in a suit alleging insulin pump maker Tandem Diabetes Care Inc.

NovemLevi, Pomerantz Seek To Lead Insulin Pump Co.

Endo pharmaceuticals address